Category Archives: People

New Roster of Players to Debate Comparative Effectiveness Standards

By William Looney | Published: January 25, 2011
Methodologies are the heart of any consistent approach to certifying comparative effectiveness for new medicines—semantics aside, it’s the way payers and providers are going to determine clinical “value” and, by subtle extrapolation, their cost against existing alternative therapies. Last week, the Patient Centered Outcomes Research Institute [PCORI] created through federal health reform legislation moved one [...]
Also posted in Regulatory, healthcare, pricing | Tagged , , , | Leave a comment

Former EMA Head Back in the Regulatory Saddle

By Julian Upton | Published: January 17, 2011
His decade-long tenure as head of the European Medicines Agency (EMA) may have ended, but Thomas Lönngren is already back in the regulatory saddle as a strategic advisor to NDA Group, an independent consulting group focused on reducing wasted drug development costs, ensuring new medicines get to market faster, and “improving the performance of the [...]
Also posted in Europe, Global, Market Access, R&D, Regulatory, leadership, pricing | Tagged , , , , | Leave a comment

Exclusive Interview: The European Medicine Agency's Thomas Lönngren

By William Looney | Published: December 14, 2010
The European Medicines Agency (EMA) is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs. In return, EMA has made a virtue of necessity. It filled the regulatory [...]
Also posted in Europe, Global, Regulatory, leadership | Tagged , , , , | 2 Comments

Pfizer: A Sudden Change at the Helm

By Jennifer Ringler | Published: December 6, 2010
Pfizer veteran insider succeeds Jeffrey Kindler as CEO—with more to come Pfizer’s Board of Directors has elected Ian C. Read, currently head of the company’s global biopharmaceutical operations, as President, CEO, and director.  Read succeeds Jeff Kindler in a transition that was sudden and unexpected:  occurring on a Sunday night, by early Monday morning Kindler’s [...]
Also posted in News, leadership | Tagged | 3 Comments

Moving On + Up – 5/6/2010

By George Koroneos | Published: May 6, 2010
Merck upped Ken Frazier to president. He had been president of Global Human Health worldwide sales and marketing. PharmAthene appointed Mitchel Sayare to its board. Michael Marine joined the Sabine Vaccine Institute as CEO. Interleukin Genetics added William Mills to its board. Rigel Pharmaceuticals was named one of the recipients of the 2010 Innovators Award of Excellence by the [...]
Posted in People | Tagged , , , , , , , | Leave a comment